Mucus-penetrating PEGylated polysuccinimide-based nanocarrier for intravaginal delivery of siRNA battling sexually transmitted infections

Colloids Surf B Biointerfaces. 2020 Dec:196:111287. doi: 10.1016/j.colsurfb.2020.111287. Epub 2020 Jul 29.

Abstract

Intravaginal delivery of siRNA for prevention of sexually transmitted infections faces obstacles such as the acidic environment and vaginal mucus barrier. To achieve effective protection and delivery of siRNA, we developed a polysuccinimide (PSI)-based nanocarrier (PSI-PEG-API-PMA, PPAP) by conjugating methoxy polyethylene glycol amine (Me-PEG-NH2, Mw 5000), 1-(3-aminopropyl)imidazole (API), and 1-pyrenemethylamine hydrochloride (PMA) to PSI. PPAP demonstrated a spherical self-assembled nanostructure before and after encapsulation of a model siRNA. Variable electrostatic interaction between API and siRNA at acidic vs. neutral pH accomplished significantly lower burst release at pH 4.2 (4 ± 1%) than pH 7.0 (26 ± 5%) within 1 h. PEGylation enabled siRNA-PPAP to achieve higher mucus penetration efficiency (64 ± 17%) than free siRNA (27 ± 5%) for 24 h. Moreover, in vitro study showed minimal toxicity, successful internalization of siRNA-PPAP in HeLa cells and improved gene knockdown (97.5 ± 0.4%). Overall, PPAP is promising for developing preventative treatments for battling sexually transmitted infections.

Keywords: HSV-2 prevention; Intravaginal nanomedicine; Mucus-penetrating siRNA nanocarrier; Polysuccinimide (PSI)-based nanocarrier; Preventing sexually transmitted infections.

MeSH terms

  • Aspartic Acid / analogs & derivatives
  • Female
  • HeLa Cells
  • Humans
  • Mucus
  • Nanoparticles*
  • Polyethylene Glycols
  • RNA, Small Interfering / genetics
  • Sexually Transmitted Diseases*

Substances

  • RNA, Small Interfering
  • poly-DL-succinimide
  • Aspartic Acid
  • Polyethylene Glycols